Register or Sign in
to unlock feature

you are not authorized to read this article.

Login or register your account to get full access to the tableting technology platform.

Login Register
Please verify your account
Please confirm your email address to validate your registration. Follow the link on email received to verify your email adress.
Re-send verification email
Please complete your registration
You're logged in but you didn't complete your registration.
Complete my registration
Exclusive content

You are not authorized to read this article.

mystylone subscription is required to view this content.

Login Register
Close search
  • Resources
  • Products & Services
    • Compaction Simulators
    • R&D / Process Support
  • Events
  • About
  • Contact Us
  • Sign in
Resources
  1. Home /
  2. Resources /
  3. Newsfeeds /
  4. Developing oral treatments, complexity is the new normal
NEWSFEEDS

Developing oral treatments, complexity is the new normal

April 03, 2025
Remove from favorites
Add to favorites

The article from The Pharma Navigator discusses the increasing challenges in developing oral drug treatments due to the growing complexity of molecules. Dr. Dan Smithey, CEO of Serán Bioscience, highlights that advancements in biology have led to the discovery of new targets affecting human diseases, necessitating more complex molecular structures, including biologics with greater structural diversity. This complexity compels the pharmaceutical industry to reevaluate drug development processes, from biological screening to formulation and manufacturing, to effectively address these challenges. Dr. Smithey emphasizes the importance of adopting a deeper scientific approach and leveraging advanced tools, such as artificial intelligence, to navigate the intricacies of modern drug development.

Read more
image developing oral treatents complixity is the new normal
manufacturing drug formulation oral drug development pharma R&D
Contributor(s):
Share Copied!
Comments

No comments posted yet.

Add a comment

Articles you may like

The Overview of Oral Solid Dosage Forms and Different Excipients Used for Solid Dosage Formulation

The overview of oral solid dosage forms and different excipients used for solid dosage formulation

first_published_at:Aug. 24, 2022, midnight / date_published:Aug. 24, 2022
Papers - 24/08/2022 - by Ms. Kiran Rameshbhai Dudhat
In the development of pharmaceutical dosage forms, the choice of excipients plays a pivotal role in both preformulation and formulation research. The physical, mechanical, and chemical attributes of excipients exert …
Navigating grades and sources of materials in drug manufacturing

Navigating grades and sources of materials in drug manufacturing

first_published_at:May 31, 2024, 2:36 p.m. / date_published:None
Newsfeeds - 31/05/2024 -
In drug manufacturing, understanding material quality—from raw materials to finished dosage forms (FDF)—is crucial. Complex global supply chains, inconsistent standards, and practical challenges in ensuring material suitability make sourcing and …
News Implemet a risk-based approach to safely manufacture HPAPIs (No)

Implement a risk-based approach to safely manufacture HPAPIs

first_published_at:June 6, 2024, 1:37 p.m. / date_published:None
Newsfeeds - 06/06/2024 -
Highly potent active pharmaceutical ingredients (HPAPIs) are increasingly used for therapeutic purposes, especially in cancer treatment. As drug manufacturers ramp up HPAPI production, they face challenges in scaling these potent …
More

Related products

Accessory_Evo_instrumented_die_2

Radial Pressure Instrumented Die - STYL'One Evo

MEDELPHARM
The axial stress impulsed by punches during powder compression induces a horizontal response called die …
Accessory_Nano_instrumented_die_4

Radial Pressure Instrumented Die - STYL'One Nano

MEDELPHARM
The axial stress impulsed by punches during powder compression induces a horizontal response called die …
illustration STYL'One Mist manual lubrication

Manual External Lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
ME-S2-300-091

Automatic External Lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
material characterization

Material Characterization

Understand powder behavior to develop robust formulations. API characterization, excipient selection, and manufacturing process determination …
STYL'One Nano scientist powder zoom

On-site Training Program - STYL'One Nano

This 1-day program, conducted in your laboratory, incorporates classroom concepts, hands-on instruction, and interactive workshops …
tablet formulation development

Tablet Formulation Development

Understand powder behavior to develop robust formulations. API characterization, excipient selection, and manufacturing process determination …
scale-up support

Scale-up Support

Transfer R&D findings to production. Successful scale-up is key for tablet manufacturing efficiency. De-risk scale-up …
process optimization

Process Optimization

Successful process optimization is key for tablet manufacturing efficiency. Optimize your production process parameters with …
process troubleshooting

Process Troubleshooting

Successful troubleshooting is key for tablet manufacturing efficiency. Adjusting process parameters (compression speed, edge thickness, …
laptop laboratory gloves

Looking for additional information?

Let us help you

Contact our experts

GENERAL

  • Terms of service
  • Privacy Policy
  • Cookie Policy
  • About
  • Contact us

Account

  • Login

Follow us on

© 2025 Medelpharm